These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

655 related items for PubMed ID: 23207944

  • 1. Quality assurance in rectal cancer treatment.
    van de Velde CJ, van den Broek CB.
    Dig Dis; 2012; 30 Suppl 2():126-31. PubMed ID: 23207944
    [Abstract] [Full Text] [Related]

  • 2. Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The Netherlands.
    Kapiteijn E, Putter H, van de Velde CJ, Cooperative investigators of the Dutch ColoRectal Cancer Group.
    Br J Surg; 2002 Sep; 89(9):1142-9. PubMed ID: 12190680
    [Abstract] [Full Text] [Related]

  • 3. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma.
    Peeters KC, Marijnen CA, Nagtegaal ID, Kranenbarg EK, Putter H, Wiggers T, Rutten H, Pahlman L, Glimelius B, Leer JW, van de Velde CJ, Dutch Colorectal Cancer Group.
    Ann Surg; 2007 Nov; 246(5):693-701. PubMed ID: 17968156
    [Abstract] [Full Text] [Related]

  • 4. [Local recurrence and survival rate after rectal cancer operations and multimodal therapy].
    Thomschke D, Kyau-Ummen B, Halbfass HJ.
    Chirurg; 2002 Mar; 73(3):245-54. PubMed ID: 11963499
    [Abstract] [Full Text] [Related]

  • 5. Cost-utility analysis of preoperative radiotherapy in patients with rectal cancer undergoing total mesorectal excision: a study of the Dutch Colorectal Cancer Group.
    Van Den Brink M, Van Den Hout WB, Stiggelbout AM, Klein Kranenbarg E, Marijnen CA, Van De Velde CJ, Kievit J, Dutch Colorectal Cancer Group.
    J Clin Oncol; 2004 Jan 15; 22(2):244-53. PubMed ID: 14665610
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Total mesorectal excision (TME) with or without preoperative radiotherapy in the treatment of primary rectal cancer. Prospective randomised trial with standard operative and histopathological techniques. Dutch ColoRectal Cancer Group.
    Kapiteijn E, Kranenbarg EK, Steup WH, Taat CW, Rutten HJ, Wiggers T, van Krieken JH, Hermans J, Leer JW, van de Velde CJ.
    Eur J Surg; 1999 May 15; 165(5):410-20. PubMed ID: 10391155
    [Abstract] [Full Text] [Related]

  • 9. Rectal carcinoma treated with short-term preoperative radiotherapy followed by abdominoperineal resection. Significantly more presacral abscesses with absence of local recurrence.
    van der Vaart MG, van der Zwet WC, Arends JW, Eeftinck Schattenkerk M, Eddes EH.
    Dig Surg; 2006 May 15; 23(3):173-7; discussion 177-8. PubMed ID: 16837787
    [Abstract] [Full Text] [Related]

  • 10. Patterns of local recurrence in rectal cancer; a study of the Dutch TME trial.
    Kusters M, Marijnen CA, van de Velde CJ, Rutten HJ, Lahaye MJ, Kim JH, Beets-Tan RG, Beets GL.
    Eur J Surg Oncol; 2010 May 15; 36(5):470-6. PubMed ID: 20096534
    [Abstract] [Full Text] [Related]

  • 11. Low rates of local recurrence after surgical resection of rectal cancer suggest a selective policy for preoperative radiotherapy.
    Senapati A, O'Leary DP, Flashman KG, Parvaiz A, Thompson MR.
    Colorectal Dis; 2012 Jul 15; 14(7):838-43. PubMed ID: 21920008
    [Abstract] [Full Text] [Related]

  • 12. Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients--a Dutch colorectal cancer group study.
    Peeters KC, van de Velde CJ, Leer JW, Martijn H, Junggeburt JM, Kranenbarg EK, Steup WH, Wiggers T, Rutten HJ, Marijnen CA.
    J Clin Oncol; 2005 Sep 01; 23(25):6199-206. PubMed ID: 16135487
    [Abstract] [Full Text] [Related]

  • 13. The impact of total mesorectal excision in middle and low rectal carcinomas.
    Tentes AA, Korakianitis OS, Veliovic D, Sgouridou E, Karagiozoglou C, Moustakas K.
    J BUON; 2010 Sep 01; 15(1):56-60. PubMed ID: 20414928
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Efforts to improve local control in rectal cancer compromise survival by the potential morbidity of optimal mesorectal excision.
    Laurent C, Nobili S, Rullier A, Vendrely V, Saric J, Rullier E.
    J Am Coll Surg; 2006 Nov 01; 203(5):684-91. PubMed ID: 17084330
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparative outcome between chemoradiotherapy and lateral pelvic lymph node dissection following total mesorectal excision in rectal cancer.
    Kim JC, Takahashi K, Yu CS, Kim HC, Kim TW, Ryu MH, Kim JH, Mori T.
    Ann Surg; 2007 Nov 01; 246(5):754-62. PubMed ID: 17968166
    [Abstract] [Full Text] [Related]

  • 20. [Total mesorectal excision versus conventional radical surgery for rectal cancer: a meta analysis].
    Liang YC, Qing SH, Ding WX, Chen PY, Huang YB, Yu HT.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Jan 01; 10(1):43-8. PubMed ID: 17253173
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.